Found 23 matching trials
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF PHASE2 This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Show More Location
Pulmonary Associates P.A.
Learn More & Join Trial
RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) PHASE2 The overall objective of this study is to evaluate the effectiveness and sa...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination PHASE4 The primary objective of this study is to investigate the effect of steady ...
Show More Location
Southmead Hospital
Learn More & Join Trial
A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications N/A To assess the impact on body mass composition from anti-fibrotic medication...
Show More Location
Royal Brompton Hospital
Learn More & Join Trial
To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF PHASE2 A participant- and investigator-blinded, randomized, placebo-controlled, mu...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients PHASE1 The primary purpose of this multi-center, double-blind, placebo-controlled,...
Show More Learn More & Join Trial
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking N/A To understand differences in characteristics of Idiopathic Pulmonary Fibros...
Show More Learn More & Join Trial
Management of Progressive Disease in Idiopathic Pulmonary Fibrosis PHASE4 Idiopathic pulmonary fibrosis (IPF) is a prototype of chronic, progressive,...
Show More Learn More & Join Trial
A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care PHASE3 The main purpose of this study was to see how GLPG1690 works together with ...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) PHASE2 This study is open to adults with idiopathic pulmonary fibrosis (IPF) who a...
Show More Location
St. Francis Medical Institute
Learn More & Join Trial